Complexes containing plasmid DNA, transferrin-polylysine conjugates, and polylysine-conjugated peptides derived from the N-terminal sequence of the influenza virus hemagglutinin subunit HA-2 have been used for the transfer of luciferase or -galactosidase marker genes to K562 cells, HeLa cells, and BNL CL.2 hepatocytes. These DNA complexes mimic the entry of viruses into cells, as they contain functions for (i) the packaging of the nucleic acid with polylysine, (i) the attachment to the cell and receptor-mediated endocytosis with transferrin as a ligand, and (Mi) the release from endosomes by using membrane-disrupting influenza peptides. The presence of these influenza peptide conjugates in the DNA complexes renders the complexes active in membrane disruption in a liposome leakage assay and results in a substantial augmentation of the transferrin-polylysine-mediated gene transfer.
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The high gene-transfer efficiency of viruses has led to the development of viral vectors in which part of the viral genome has been replaced by a gene to be introduced into eukaryotic cells. These recombinant viral vectors such as adenoviral (1, 2) , retroviral (3, 4) , vaccinia (5, 6), and parvoviral (7, 8) vectors have displayed useful gene delivery properties in a large number of applications. However, these vectors are limited in their cell tropism, in the size ofthe gene to be introduced, and in that the introduced DNA must be compatible with viral replication. Our approach to establish an efficient gene transfer device is based on the concept of adopting distinct viral entry functions and combining them in a modular fashion.
Viruses contain core proteins in their interior that package their nucleic acid genome into small compact structures. The surface proteins of many viruses (for instance adenoviruses, alphaviruses, orthomyxoviruses, or picornaviruses) contain two further functions essential for the delivery of the viral genome into the cytoplasm of the target cells: (i) the binding of the virus particle to a cellular surface receptor that mediates endocytosis of the virion into endosomes, and (ii) after endocytosis, the release of the viral genome from endosomes into the cytoplasm by disruption of the endosomal membrane, in the case of membrane-free viruses (such as adenoviruses), or the fusion of the viral membrane with endosomal membranes, in the case of enveloped viruses (such as influenza virus). Viruses that enter via this endosomal route are thought to exploit the endosomal acidification process, which specifically activates their endosomolytic or fusogenic protein domains. This has been demonstrated in detail for the influenza viruses (9) . We, and others (10, 11) , have used the cellular mechanism of receptor-mediated endocytosis of macromolecules or viruses, employing ligands such as transferrin (12) (13) (14) or viral proteins (15) , for the import ofDNA molecules into cells. The key steps have been the conjugation ofthe ligand for a certain cell receptor to a DNA-binding moiety, such as a polycation or an intercalating compound, and the formation of complexes of this conjugate with the DNA to be delivered. We have demonstrated that polylysine conjugates condense the DNA into small structures with a size of 80-100 nm (14) , which approximate the size of many viruses. These DNA complexes, however, still lack the second important function of viral entry-namely, a mechanism for escape from endosomes, which is a limiting step for reporter gene expression during receptor-mediated gene delivery (16) .
In the present communication, we describe the inclusion of fusogenic peptides derived from the N-terminal sequence of the influenza virus hemagglutinin subunit HA-2 as part of the DNA complexes and the resulting augmentation of gene transfer to cultured cells. These DNA complexes, containing polylysine as the nucleic acid packaging module, polylysine-modified transferrin as the receptor binding module, and polylysine-bound influenza peptides as the endosomolytic module, represent a simple model of an artificial membrane-free virus without replication functions, which can be used to deliver genes to eukaryotic cells.
MATERIALS AND METHODS
Materials. Human transferrin-poly(L-lysine) conjugates with an average chain length of 190 lysine residues (TfpL19OB) or 290 lysine residues (TfpL290) were prepared as described (17) . Nl-undecyl-polylysine (C11pL) was synthesized by reaction of the trifluoroacetate salt of poly-(L-lysine) ( Phe-Glu-Ala-lle-Ala-Gly-Phe-lle-Glu-Asn-Gly-Trp-Glu-GlyMet-Ile-Asp-Gly-Gly-Gly-Cys was synthesized by the fluoren-9-ylmethoxycarbonyl (Fmoc) procedure (18) Peptide 2 (with Glu-4 of peptide 1 changed to Gly) was synthesized in a manner analogous to peptide 1. A control peptide 3 with the same amino acid composition as peptide 1, but with the scrambled sequence Phe-Leu-Gly-Ile-Ala-GluAla-Ile-Asp-Ile-Gly-Asn-Gly-Trp-Glu-Gly-Met-Glu-PheGly-Gly-Gly-Cys, was also synthesized.
Conjugation of Influenza Peptides to Polylysine. Polylysine with an average chain length of 300 lysine residues (pLys300; Liposome Leakage Assays. Liposomes of phosphatidylcholine (Avanti Polar Lipids) containing 100 mM calcein (adjusted to pH 7.3 by addition of sodium hydroxide) were prepared by using the reverse-phase evaporation method (20, 21) . The liposome mixture was extruded several times through a Nucleopore polycarbonate membrane (100 nm). The liposomes were separated from nonincorporated material by gel filtration (Sephadex G-50; Pharmacia). The lipid phosphorus of the resulting liposome solution was determined by using the method of Bartlett (22) . Leakage of liposomal contents in the presence of various lysogenic peptides or derivatives was measured by the release of entrapped calcein (23) . The calcein fluorescence was measured at 515 nm (excitation at 490 nm). Aliquots of the above liposome solution were diluted 100-fold (final concentration, 25 ,uM lipid) with 0.15 M sodium chloride/citrate buffers of the appropriate pH (4.5-7.3). To 1 ml of these solutions was added 0.5 ,g of peptide (t-butyl-protected form at 0.2 ,g/,u in HBS), while mixing with a gentle stream of argon (final concentration, 0.2 AM peptide). The values corresponding to 100% leakage were determined by complete lysis of liposomes after the addition of 5 ,ul of 10% Triton X-100 (Fluka).
Cells, DNA Complex Formation, and Transfections. K562 cells were grown in suspension in RPMI 1640 medium (GIBCO/BRL) containing 10% fetal calf serum (FCS), penicillin at 100 units/ml, streptomycin at 100 pg/ml, and 2 mM glutamine. At 20 hr before transfection, the cells were placed in fresh medium containing 50 ,uM desferrioxamine (13 (27) . We have observed an increased tendency ofthe wild-type sequence (peptide 2) to lose some of the leakage activity upon storage at 4TC in physiological buffer at pH 7.3, which may be explained by partial self-aggregation. In contrast, the acidic mutant peptide 1 does not display this behavior.
The peptides were linked to polylysine by reacting the cysteine mercapto groups with pyridyldithio-modified polylysines to yield disulfide-conjugated peptide-polylysine derivatives. The conjugates InflulpL, derived from peptide 1, and Influ2pL, derived from peptide 2, with one to eight influenza peptides per polylysine chain were prepared (see Materials and Methods). In the liposome leakage assay, the peptide conjugate InflulpL had a higher activity than unconjugated peptide 1 (Fig. 1B) . The conjugate InflulpL still showed a pH dependence but, in contrast to free peptide 1, had significant activity at neutral pH. Unmodified polylysine had no leakage activity; polylysine conjugated to the control peptide 3 (Influ3pL) had very low activity. A lipophilic polylysine, modified with undecyl groups (C11pL), showed a moderate, pH-independent activity in this assay (Fig. 1B) .
Complexing the peptide-polylysine conjugate with DNA reduced the leakage activity again, in particular the activity at neutral pH (Fig. 1B) .
Luciferase Gene Delivery by DNA Combination Complexes Containing Transferrin and Membrane-Disruptive Peptides. Combination complexes consisting of plasmid DNA encoding the Photinus pyralis luciferase (pCMVL) as a reporter gene, transferrin-polylysine, and peptide-polylysine conjugates were prepared by adding transferrin-polylysine to DNA to neutralize half of the DNA charge; the remainder of the charge was then saturated by addition of influenza peptide-polylysine conjugate. The standard transferrinfection to the erythroleukemic cell line K562 requires the presence of chloroquine (13) . In the absence of this lysosomatropic agent, no subsequent gene expression occurred with either transferrin-polylysine-complexed DNA or polylysine-complexed DNA (Fig. 2) . The combination complexes containing the influenza peptide conjugate, however, particularly if transferrin-polylysine was included as the receptor-binding component, showed high luciferase expression (Fig. 2) . Neither unconjugated peptide (data not shown) nor polylysine modified with lipophilic undecyl residues (Fig.  2) be replaced by lipophilic modifications, although these modifications allow polylysine to disrupt membranes to a moderate degree, albeit in a pH-independent manner (see Fig. 1 ). Similar gene transfer experiments were performed with HeLa cells that, even in the presence of chloroquine, showed only a moderate transferrinfection efficiency. The data shown in Fig. 3 demonstrate the importance of including the peptide conjugate in the DNA-transferrin-polylysine complex. Incorporation of peptide-polylysine conjugates into complexes, where only half of the plasmid DNA is complexed with transferrin-polylysine [TfpL(4,gg)+Influ1pL], resulted in an over 100-fold improvement over TfpL-DNA complexes alone. When the DNA was first completely saturated with transferrin conjugates [TfpL(8,ug)+Influ1pL], the additional free lysogenic conjugate (which cannot bind the DNA) still had some effect, but a much lower one than if the peptide was part of the complex. Free peptides 1 and 2 had no promoting effect on gene transfer, but clearly showed toxic effects at higher concentrations. In the special case of HeLa cells, unmodified polylysine exerted a considerable, but less pronounced, enhancement of the transferrinpolylysine-mediated gene transfer than the peptidepolylysine conjugates (see Fig. 6 ). This unspecific polylysine effect in HeLa cells was blocked by raising the serum content of the medium to 10-20o (data not shown).
Different combination complexes consisting of DNA, transferrin-polylysine, and optimum amounts of the peptide conjugate InflulpL or one of the three Influ2pL conjugates with different peptide-to-polylysine ratios were tested for gene transfer efficiency to the murine hepatocytic cell line BNL CL.2 (Fig. 4A) (Fig. 4B) . The conjugates of influenza peptides 1 and 2 showed comparable augmentation of the gene transfer to hepatocytes.
A comparison of several transferrin-polylysine-mediated gene transfer procedures is shown in Fig. 5 . The standard transferrinfection to BNL CL.2 cells using DNA-transferrinpolylysine complexes resulted in limited gene expression in both the absence and presence of chloroquine (Fig. 5) increased gene expression. In combination with chloroquine, the gene expression was further enhanced (see Discussion).
(-Galactosidase Gene Delivery to HeLa Cells and Detection of Expression at the Cellular Level. DNA complexes containing a 3galactosidase reporter gene were used for delivery to HeLa cells, and the subsequent gene expression was visualized on the cellular level (Fig. 6) . Using transferrinpolylysine-complexed DNA, only a few cells (-1 in 1000) expressed f3galactosidase (data not shown). Combination complexes, additionally including the influenza peptide conjugate InflulpL, showed a strong expression of 3galacto-sidase in 3-10% of the cells (Fig. 6A) . The control experiment with complexes containing transferrin-polylysine conjugates together with comparably high amounts of unmodified polylysine resulted in expression in =0.5% of the cells (see Fig.  6B (28) complexes were carried out as described in Fig. 3 . After 48 hr, staining reactions were performed for 1 hr (see Materials and Methods). four expressing cells 48 hr after transfection, which correlates with a progression through two cell cycles.
DISCUSSION
When complexes of the transferrin-polylysine conjugate (12, 17) and DNA are incubated with cells, the complexes bind to the transferrin receptors and are internalized by the cells, leading to expression of genes contained within the DNA (13, 29) . In order to obtain high levels of gene expression, measures have to be taken to protect the DNA from degradation in lysosomes and/or release it from intracellular vesicles into the cytoplasmic compartment and finally into the nucleus of the cell (15). The approach described here makes use of the efficient mechanisms that many viruses (for instance, adenovirus and influenza virus) employ for the release from endosomes. Instead of using whole free viruses, we have taken synthetic fusogenic peptides derived from an influenza virus envelope protein and linked them to a complex containing DNA, transferrin, and polylysine, with the hope that the activity, which in its natural context causes fusion with the endosomal membrane, may disrupt endosomes in the context of our artificial complexes. In the case of influenza virus, the fusion activity has been extensively studied (30) . The factor responsible for fusion of viral and endosomal membranes is the viral membrane glycoprotein hemagglutinin, a homotrimer, each monomer of which consists of two polypeptides, HA-1 and HA-2, connected through a disulfide bond (31) . The membrane fusion activity is triggered by an acid-induced change, which exposes the highly conserved hydrophobic N-terminal region of the HA-2 subunit, allowing it to interact with the endosomal membrane. Synthetic peptides corresponding to the N terminus of influenza HA-2 are able to fuse artificial lipid membranes and cause leakage of aqueous liposomal contents (27, 32) . Such peptides were shown to increase their a-helicity when interacting with lipid membranes (27, 32 (Fig. 1) . Peptide 1 has leakage activity only at low pH. This is consistent with the model that the (Fig. 4) . The polylysine conjugates of the two different peptide sequences show no significant differences in the gene transfer-enhancing activities.
Inclusion of chloroquine shows a promoting effect on the gene-transfer complexes, suggesting that the entry occurs via an endocytic pathway (Fig. 5) . The synergistic effect of chloroquine (which raises the pH of internal vesicles and therefore should reduce the peptide's pH-dependent leakage activity) was unexpected but can be explained by a protection of the conjugates from lysosomal degradation, by osmotic destabilization of the endocytic vesicles by internal accumulation of chloroquine (25, 33) , and/or by the observation that the influenza peptide conjugates display some residual leakage activity at neutral pH.
Expression of a galactosidase reporter gene in HeLa cells (Fig. 6) demonstrates that the influenza peptide conjugates facilitate transferrinfection up to a level of high expression in about 5-10%6 of all cells. This frequency is low compared to the transferrinfection performed in the presence of free or DNA-bound defective adenoviruses (34, 35) where frequencies of 290%o are observed. However, with the use of whole virus, some cytopathic effects on the transfected cell population can be observed (34) . With the DNA complexes containing the membrane-disruptive peptides, no toxic effects have been found.
Our transport complexes can be likened to artificial viruses that mimic the viral transfer ofgenes into cells but are devoid of all cytopathic and replicative functions of natural viruses. Once higher efficiencies of gene transfer have been obtained, such artificial viral complexes may become the method of choice. The present report may be considered as a first step toward this goal. The model complexes described here contain amphipathic peptides as the minimal functional unit for specific membrane disruption but lack the ordered architecture of viral surfaces thought to mediate optimal entry.
